272 related articles for article (PubMed ID: 15199465)
1. Oral anticoagulant therapy in subjects with congenital or acquired thrombophilia.
Baglin T
Semin Vasc Med; 2003 Aug; 3(3):315-22. PubMed ID: 15199465
[TBL] [Abstract][Full Text] [Related]
2. [Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia].
Poli D; Gensini GF
Ann Ital Med Int; 2005; 20(4):218-23. PubMed ID: 16610253
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
4. Should patients with venous thromboembolism be screened for thrombophilia?
Dalen JE
Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222
[TBL] [Abstract][Full Text] [Related]
5. Venous thrombosis in the antiphospholipid syndrome.
Farmer-Boatwright MK; Roubey RA
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
7. Role of thrombophilia in deciding on the duration of anticoagulation.
Bauer KA
Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
9. Management options for thrombophilias.
Gallus AS
Semin Thromb Hemost; 2005 Feb; 31(1):118-26. PubMed ID: 15706484
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.
; ; ; ; Nicolaides AN; Breddin HK; Carpenter P; Coccheri S; Conard J; De Stefano V; Elkoofy N; Gerotziafas G; Guermazi S; Haas S; Hull R; kalodiki E; Kristof V; Michiels JJ; Myers K; Pineo G; Prandoni P; Romeo G; Samama MM; Simonian S; Xenophonthos S
Int Angiol; 2005 Mar; 24(1):1-26. PubMed ID: 15876995
[TBL] [Abstract][Full Text] [Related]
11. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
12. The treatment of venous thromboembolism in special populations.
Rondina MT; Pendleton RC; Wheeler M; Rodgers GM
Thromb Res; 2007; 119(4):391-402. PubMed ID: 16879860
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
James AH; Brancazio LR; Ortel TL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
[TBL] [Abstract][Full Text] [Related]
14. Long-term management of patients after venous thromboembolism.
Kearon C
Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome and recurrent thrombosis in children.
Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome.
Crowther MA
Thromb Res; 2004; 114(5-6):443-6. PubMed ID: 15507276
[TBL] [Abstract][Full Text] [Related]
17. Hereditary thrombophilia and venous thromboembolism: critical evaluation of the clinical implications of screening.
Mazzolai L; Duchosal MA
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):483-8. PubMed ID: 17588784
[TBL] [Abstract][Full Text] [Related]
18. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
Crowther MA; Wisloff F
Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
[TBL] [Abstract][Full Text] [Related]
19. [Current criteria to determine the duration of anticoagulant therapy].
Palareti G
Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
[TBL] [Abstract][Full Text] [Related]
20. Treatment of deep vein thrombosis.
Couturaud F; Kearon C
Semin Vasc Med; 2001; 1(1):43-54. PubMed ID: 15199513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
